CompletedPhase 1NCT03590392

Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Adrian V Hill, DPhill FRCP
Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, United Kingdom
Intervention
ChAdOx1 Chik(biological)
Enrollment
24 enrolled
Eligibility
18-50 years · All sexes
Timeline
2018 – 2019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03590392 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials